A selective p53 activator and anticancer agent to improve colorectal cancer therapy-Reference-Cited by-同舟云学术

A selective p53 activator and anticancer agent to improve colorectal cancer therapy

Published:2021-04 Issue:2 Volume:35 Page:108982
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Ramos Helena,Soares Maria I.L.,Silva Joana,Raimundo Liliana,Calheiros Juliana^ORCID,Gomes Célia,Reis Flávio,Monteiro Filipe A.,Nunes Cláudia,Reis Salette,Bosco Bartolomeo,Piazza Silvano,Domingues Lucília,Chlapek Petr,Vlcek Petr^ORCID,Fabian Pavel,Rajado Ana Teresa,Carvalho A.T.P.,Veselska Renata,Inga Alberto,Pinho e Melo Teresa M.V.D.,Saraiva Lucília

Funder

FCT

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference71 articles.

1. ETV7-Mediated DNAJC15 Repression Leads to Doxorubicin Resistance in Breast Cancer Cells;Alessandrini;Neoplasia,2018

2. Post-translational modifications and activation of p53 by genotoxic stresses;Appella;Eur. J. Biochem.,2001

3. Changes in colorectal cancer incidence in seven high-income countries: a population-based study;Araghi;Lancet Gastroenterol. Hepatol.,2019

4. Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding;Banker;J. Pharm. Sci.,2003

5. Cyclodextrin/imatinib complexation: binding mode and charge dependent stabilities;Béni;Eur. J. Pharm. Sci.,2007

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self-assembled IR dye/mitoxantrone loaded Porphysomes nanosystem for enhanced combinatorial chemo-photothermal cancer therapy;Colloids and Surfaces B: Biointerfaces;2024-09

2. Unveiling the Mechanisms of EGCG–p53 Interactions through Molecular Dynamics Simulations;ACS Omega;2024-04-23

3. Insight on Heterocycles as p53‐MDM2 Protein‐Protein Interaction Inhibitors: Molecular Mechanism for p53 Activation;ChemistrySelect;2024-03-06

4. Targeted regulated cell death with small molecule compounds in colorectal cancer: Current perspectives of targeted therapy and molecular mechanisms;European Journal of Medicinal Chemistry;2024-02

5. Camptothecin structure simplification elaborated new imidazo[2,1-b]quinazoline derivative as a human topoisomerase I inhibitor with efficacy against bone cancer cells and colon adenocarcinoma;European Journal of Medicinal Chemistry;2024-02